Tebra (formerly Kareo) red flags & complaints

Verified public risk signal level for Tebra (formerly Kareo): none (as of June 15, 2026).

No material public risk signals as of 2026-06-15.

Signals on file

None. We searched data breaches, court filings, BBB billing complaints, and support-rating trend lines — nothing material surfaced as of our last verification.

What customers criticise (separate from risk signals)

Its clinical features are less robust than those of competitors focused on complex specialties, and it lacks the deep interoperability needed for larger health systems.

If you’re reconsidering

See alternatives to Tebra (formerly Kareo), or read the full Tebra (formerly Kareo) review.

Where else this brand ranks

Source: Top 11 risk-signal review, last checked June 15, 2026. We publish complaints, not compliments. File a new complaint.